Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOLIMUMAB vs GRANISETRON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GOLIMUMAB vs GRANISETRON: Safety Overview

Metric GOLIMUMAB GRANISETRON
Total FAERS Reports 69,222 2,547
Deaths Reported 4,866 417
Death Rate 7.0% 16.4%
Hospitalizations 15,471 441
Average Patient Age 53.0 yrs 52.9 yrs
% Female Patients 79.2% 61.1%
FDA Approval Date N/A Apr 29, 2008
Manufacturer Janssen Biotech, Inc. Eugia US LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued